A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin
Fahad Aleidan, Ghada A. Aljarba, Alaa A. Aldakhil, Batol I. Allehyani, Madona A. Yahia, Nuorah E. Alghtani, Motasem Badri, Ali Alaklabi, Ahmad Alsuhaibani, Mark Crowther
Topics & Concepts
MedicinePregnancyLow molecular weight heparinProspective cohort studyVenous thromboembolismConfidence intervalHeparinObstetricsHematologyCohort studyRisk factorInternal medicineThrombosisBiologyGeneticsBlood Coagulation and Thrombosis MechanismsVenous Thromboembolism Diagnosis and ManagementHeparin-Induced Thrombocytopenia and Thrombosis